SEARCH

SEARCH BY CITATION

Acknowledgements

These studies were supported by an NARSAD Young Investigator Award, a grant from the Foundation of the University of Medicine and Dentistry of New Jersey, and by NIMH grant MH60100 to D.S.C. We thank Dr. John Kehrl (NIAID, NIH) for kindly providing the cDNA for human RGS4.

  • 1
    Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1.EMBO J. 15 65416551.
  • 2
    Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., Cohen P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.Curr. Biol. 7 261269.
  • 3
    Berg K.A., Clarke W.P., Sailstad C., Saltzman A., Maayani S. (1994) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.Mol. Pharmacol. 46 477484.
  • 4
    Burchett S.A., Bannon M.J., Granneman J.G. (1999) RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration.J. Neurochem. 72 15291533.
  • 5
    Cobb M. & Goldsmith E. (1995) How MAP kinases are regulated.J. Biol. Chem. 270 1484314846.
  • 6
    Denton R.M. & Tavare J.M. (1995) Does mitogen-activated-protein kinase have a role in insulin action?Eur. J. Biochem. 227 597611.
  • 7
    De Vries L. & Farquhar M.G. (1999) RGS proteins: more than just GAPs for heterotrimeric G proteins.Trends Cell Biol. 9 138143.
  • 8
    Dickenson J.M. & Hill S.J. (1995) Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis-sensitive mechanism in CHO-K1 cells. Br. J. Pharmacol. 116 28892896.
  • 9
    Druey K.M. & Kehrl J.H. (1997) Inhibition of regulator of G protein signaling function by two mutant RGS4 proteins.Proc. Natl. Acad. Sci. USA 94 1285112856.
  • 10
    Druey K.M., Blummer K.J., Kang V.H., Kehrl J.H. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family.Nature 379 742746.
  • 11
    Giles H., Lansdell S.J., Bolofo M.L., Wilson H.L., Martin G.R. (1996) Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.Br. J. Pharmacol. 117 11191126.
  • 12
    Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).Pharmacol. Rev. 46 157203.
  • 13
    Huang C., Hepler J.R., Gilman A.G., Mumby S.M. (1997) Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc. Natl. Acad. Sci. USA 94 61596163.
  • 14
    Mendez J., Kadia T.M., Somayazula R.K., El-Badawi K.I., Cowen D.S. (1999) Differential coupling of serotonin 5-HT1A and 5-HT1B receptors to activation of ERK2 and inhibition of adenylyl cyclase in CHO cells.J. Neurochem. 73 162168.
  • 15
    Ni Y.G., Gold S.J., Iresdale P.A., Terwilliger R.Z., Duman R.S., Nestler E.J. (1999) Region-specific regulation of RGS4 (regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies.J. Neurosci. 19 36743680.
  • 16
    Potenza M.N., Gold S.J., Roby-Shemkowitz A., Lerner M.R., Nestler E.J. (1999) Effects of regulators of G-protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay.J. Pharmacol. Exp. Ther. 291 482491.
  • 17
    Pullarkat S.R., Mysels D.J., Tan M., Cowen D.S. (1998) Coupling of serotonin 5-HT1B receptors to activation of mitogen-activated protein kinase (ERK-2) and p70 S6 kinase signaling systems.J. Neurochem. 71 10591067.
  • 18
    Scalzitti J.M. & Hensler J.G. (1996) Serotonin receptors: role in psychiatry, inHandbook of Psychiatric Genetics (Blum K. and Noble E. P., eds), pp. 113145. CRC Press, Boca Raton.
  • 19
    Unsworth C.D. & Molinoff P.B. (1992) Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists.Mol. Pharmacol. 42 464470.
  • 20
    Veldman S.A. & Bienkowski M.J. (1992) Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.Mol. Pharmacol. 42 439444.
  • 21
    Xu X., Zeng W., Popov S., Berman D.M., Davignon I., Yu K., Yowe D., Offermanns S., Muallem S., Wilkie T.M. (1999) RGS proteins determine signaling specificity of Gq-coupled receptors. J. Biol. Chem. 274 35493556.
  • 22
    Yan Y., Chi P.P., Bourne H.R. (1997) RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis.J. Biol. Chem. 272 1192411927.
  • 23
    Zeng W., Xu X., Popov S., Mukhopadhyay S., Chidiac P., Swistok J., Danho W., Yagaloff K.A., Fisher S.L., Ross E.M., Muallem S., Wilkie T.M. (1998) The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling.J. Biol. Chem. 273 3468734690.